Comparison of the Effects of Oral Sirolimus and Oral Cyclosporine on the Thrombocytopenic Chronic Purpura

Phase 3

• Conditions: Idiopathic thrombocytopenic purpura.; Immune thrombocytopenic purpura; D69.3

• Registration Number: IRCT20180501039499N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Children aged 5 to 15 years with chronic idiopathic thrombocytopenic purpura
Not having any other blood diseases
Parental informed consent

Exclusion Criteria

Increase BUN / CR or decrease GFR by less than 50 ml / day.
Seizure
Allergic reaction
Oral drug intolerance
No response to drug treatment after 3 months.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Idiopathic thrombocytopenic purpura. Timepoint: Platelet measurement at the beginning of the study, months 1 to 6 after treatment. Method of measurement: The number of platelets is measured by using the Cell counter sysmax device.